Amedisys (NASDAQ:AMED) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Amedisys beat estimated earnings by 19.51%, reporting an EPS of $1.47 versus an estimate of $1.23.
Revenue was down $6.28 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 2.64% increase in the share price the next day.
Here's a look at Amedisys's past performance:
To track all earnings releases for Amedisys visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
